2026 AHFTC Board Certification Review - OnDemand
Program Overview

The 2026 AHFTC Board Certification Review OnDemand is a comprehensive educational program developed by the Heart Failure Society of America (HFSA) to help physicians prepare for the American Board of Internal Medicine (ABIM) Advanced Heart Failure and Transplant Cardiology (AHFTC) Certification Examination or to provide a comprehensive review of contemporary heart failure practice.

Designed and delivered by nationally recognized experts, this self-paced program provides an in-depth review of the knowledge and clinical competencies outlined in the current ABIM examination blueprint while emphasizing practical, evidence-based management of patients with advanced heart failure and transplantation.

Why Choose This Course?

  1. Comprehensive review aligned with the current ABIM AHFTC Examination Blueprint
  2. More than 23 hours of expert-led education
  3. Nationally recognized faculty from leading heart failure and transplant programs
  4. Board-style examination questions with detailed explanations
  5. Curated 2026 Reading List featuring landmark clinical trials and current guidelines
  6. Downloadable presentation slides
  7. CME, Nursing Continuing Education, and ABIM MOC credit opportunities

 

Target Audience
This program is idea for: 
  • Physicians preparing for the ABIM AHFTC Board Certification or MOC exams
  • Cardiologists, HF specialists, and transplant clinicians seeking high-level clinical updates
  • Advanced practice providers and multidisciplinary HF team members who want comprehensive, practical education in advanced heart failure and transplant care
What is included:
Pre-Meeting OnDemand Presentations
Sixteen self-paced presentations designed to build a strong foundation in the core knowledge domains tested on the board examination.

HFSA AHFTC Board Review Course Recordings
Complete recordings from the 2026 AHFTC Board Certification Review featuring comprehensive faculty lectures and board-focused clinical discussions.

Study Resources
  • HFSA AHFTC Question Bank
  • 2026 Recommended Reading List
  • Presentation slides 
Recommended Learning Pathway

To maximize your learning experience and successfully complete the program, we recommend progressing through the course in the following order:

Step 1 – Watch the Pre-Meeting OnDemand Presentations
Build a strong foundation by reviewing the 16 self-paced presentations covering core concepts tested on the ABIM AHFTC Certification Examination.

Step 2 – Watch the 2026 HFSA AHFTC Board Certification Review Recordings
Continue with the recorded presentations from the live Board Review course, featuring comprehensive reviews of high-yield topics, board-style cases, and practical clinical insights from expert faculty.

Step 3 – Complete the Study Resources
Reinforce your learning by working through the HFSA AHFTC Question Bank and reviewing the 2026 Recommended Reading List.

Step 4 – Complete the Post-Examination and Course Evaluation
Demonstrate your knowledge by passing the post-examination and completing the course evaluation to fulfill the activity requirements.

Step 5 – Claim Your Certificate
Once all course requirements have been completed, access your continuing education certificate and transcript from your Learning Center account. Eligible ABIM Maintenance of Certification (MOC) points will be automatically reported to ABIM.

Learning Objectives

This course is designed to:
1.    Review testable content and the focus of the ABIM Advanced Heart Failure and Transplant Cardiology Certification Examination.
2.    Identify gaps in knowledge about advanced heart failure and transplant cardiology.  
3.    Explain how to best focus study efforts on filling identified knowledge gaps.  
4.    Provide practice for the certification examination with ABIM-style multiple-choice test questions.


For Clinical Practice:
  1. Describe the epidemiology of heart failure, including environmental factors, and implement strategies for the prevention of heart failure.
  2. Discuss the pathophysiology of heart failure, including normal physiology and compensatory and maladaptive mechanisms.
  3. Assess and treat patients with acute or advanced heart failure, using non-invasive and invasive tests and biomarkers.
  4. Apply guideline-based therapy for patients with chronic heart failure, including pharmacologic agents; non-pharmacologic options, such as diet and exercise; and implantable devices.
  5. Incorporate appropriate care strategies for patients undergoing chemotherapy or with pulmonary hypertension, heart failure with preserved ejection fraction, valvular heart disease, pregnancy-associated disease, and cardiorenal syndrome.
  6. Explain the genetic basis of cardiomyopathies, including hypertrophic cardiomyopathy, and recognize when to pursue genetic testing as part of the evaluation of patients with suspected inherited heart failure syndromes.
  7. Manage comorbidities in patients with chronic heart failure, including sleep-disordered breathing, anemia, and diabetes.
  8. Implement strategies for effective disease management of patients with advanced heart failure, including referral for mechanical circulatory support, heart transplant, or palliative care.
  9. Manage immunosuppressive therapies and common complications of heart transplant, including rejection, allograft vasculopathy, and immunosuppression-associated conditions.
  10. Utilize mechanical support devices, both temporary and durable.
  11. Manage common complications of mechanical circulatory support.
Curriculum
Pre-Meeting OnDemand Presentations
  • Cardio-Oncology for the HF Boards - Bonnie Ky 
  • Clinico-Pathologic Correlates in Heart Failure/ Images for the Heart Failure Boards - Jon Lomasney 
  • DM, Obesity/CKM - Amanda Vest 
  • Diagnosis and Clinical Assessment - Mark Drazner 
  • Healthcare Disparities in HF - Khadijah Breathett 
  • Heart Failure Epidemiology and Risk Factors - Clyde Yancy 
  • Hemodynamics in HF Virtural - James C. Fang 
  • Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions) - Akshay Desai 
  • Management of Comorbidities in Heart Failure - Sleep Disorders  - Robert Mentz 
  • Optimal Medical Therapy for HFrEF Virtual - Mark Drazner 
  • Pathophysiology 1: Cellular and Energetic Considerations - Daniel Burkhoff 
  • Pathophysiology 2: Hemodynamic, Structural and Neurohormonal Considerations - Daniel Burkhoff 
  • Pulmonary Hypertension - Classification and Initial Evaluation - Yasmin Raza 
  • Pulmonary Hypertension – Treatment - Yasmin Raza 
  • RV Failure and TR Management - Barry Borlaug 
  • Statistics for the HF Board - Brian Claggett 
2026 Board Review Course Recordings 
  • Hemodynamics in HF Live - James C. Fang 
  • Optimal Medical Therapy for HFrEF Live - Mark Drazner 
  • Cardio Renal Failure Interactions in Heart Failure - Wendy McCallum 
  • Assessment of Functional Capacity including cardiopulmonary exercise testing - Gregory Lewis 
  • HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (For the Boards) - Ravi Patel 
  • Management of Comorbidities in Heart Failure: Iron Deficiency/Anemia - Gregory Lewis 
  • Specific Etiologies of HF 1: HCM - Jane Wilcox 
  • Specific Etiologies of HF 2: Other Inherited HF syndromes - Jane Wilcox
  • Specific Etiologies of HF 3: Infiltrative Disorders and Restrictive CMP - Jennifer Cowger
  • Specific Etiologies of HF 4: Myocarditis and Inflammatory Cardiomyopathies - Jennifer Cowger 
  • Management of the Hospitalized HF Patient - Alpesh Amin 
  • Management of Left Sided Valvular Heart Disease in Heart Failure - Jane Wilcox 
  • Management of Common Arrhythmias 1 & 2 - Susan Kim 
  • Adult Congenital Heart Disease for the HF Specialist - Eric Krieger 
  • Pregnancy in HF - Sarah Goldstein 
  • Immunology: The Basics, PRA, Sensitization, Crossmatch - Palak Shah 
  • Rejection: Cellular and Antibody Mediated - Palak Shah 
  • Heart Transplant, Clinical Outcomes and Complications - Michelle Kittleson 
  • Managing Immunosuppression and Drugs - Michelle Kittleson 
  • Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies - Mark Belkin 
  • Cardiogenic Shock Management - Esther Vorovich 
  • Device Therapy in Heart Failure I - Sudden Death Prevention - Theofanie Mela 
  • Device Therapy in Heart Failure II - CRT - Theofanie Mela 
  • MCS 1: Durable MCS Devices and Outcomes - Jennifer Cowger 
  • MCS 2: Temporary Support Devices and ECMO for the Boards - Shashank Sinha 
  • MCS 3: Management of complications of MCS - Shashank Sinha 
  • MCS 4: Interactive Shock and Device Management - Daniel Burkhoff
Credit Education Credit Available


In support of improving patient care, The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Heart Failure Society of America designates this educational activity for a maximum of 23.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 
  
Successful completion of this activity, which includes participation in the evaluation component and post-test with 75% passing score, enables the participant to earn up to 23.50 MOC contact hours in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program.

This educational activity is approved for nursing continuing professional development (NCPD) units by the Heart Failure Society of America. This activity is approved for a maximum of 23.50 NCPD contact hours. 

Learners should claim only the credit commensurate with the extent of their participation in the activity. 

Summary
Availability:
Expires on Jul 14, 2027
Cost:
Member: $1,599.00
Non-Member: $2,199.00
Credit Offered:
23.5 CME Credits
23.5 MOC Points
23.5 NCPD Credits
Contains:
Powered by Oasis.
Powered By